Azaindoles for inhibiting aurora2 and other kinases
US7943616B2 · kind B2 · utility
55Cited by
16References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2004 |
| Grant date | May 17, 2011 |
| Priority date | — |
| Expiry date | Nov 23, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to physiologically active compounds of general formula (I):—and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.